RCGP Comment On MHRA Announcemnet Re: NSAIDs And Coxibs

Main Category: Arthritis / Rheumatology
Also Included In: Pain / Anesthetics
Article Date: 28 Oct 2006 - 10:00 PDT

email to a friend   printer friendly   opinions  

RCGP comment on the announcement made by the Medicines and Healthcare Products Regulatory Agency (MHRA) on the safety of selective and non-selective NSAIDs.

"The Royal College of General Practitioners (RCGP) would like to reassure patients who are on a small dose of non-selective NSAIDs and coxibs for a short period of time that this study indicates little risk. For patients on a high dosage for a long period of time, there is a small increase in risk but they should discuss this or any other concerns with their GP at their next routine appointment or with their pharmacist. GPs will work with patients to select a drug and a dosage that is right for them based on this latest information and on the patient's clinical history.

"The RCGP would like to reiterate its longstanding advice to restrain the use of NSAIDs and coxibs for definite clinical indications to the lowest possible dose and for the shortest period of time. If long term treatment is needed, then that need must be reviewed periodically."

Professor Mayur Lakhani, RCGP Chairman

###

For further information please go to:
Royal College of General Practitioners

• Additional
• References
• Citations